LEADER 01293oam  2200373Ia 450 
001 9910698935003321
005 20090714160846.0
035   $a(CKB)5470000002398527
035   $a(OCoLC)424621679
035   $a(EXLCZ)995470000002398527
100   $a20090714d2006      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $epharmacovigilance of veterinary medicinal products, management of adverse event reports (AER's)
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Veterinary Medicine,$d[2006]
215   $a9 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on July 13, 2009).
300   $a"VICH GL24".
300   $a"Draft guidance".
300   $a"May 1, 2006".
517   $aGuidance for industry 
606   $aVeterinary drugs$xSide effects$xReporting
615  0$aVeterinary drugs$xSide effects$xReporting.
712 02$aCenter for Veterinary Medicine (U.S.)
801  0$bGPO
801  1$bGPO
801  2$bGPO
906   $aBOOK
912   $a9910698935003321
996   $aGuidance for industry$93434577
997   $aUNINA